Leisure Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LACQ and buy or sell other stocks, ETFs, and their options commission-free!About LACQ
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
CEOD. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees9
Employees9
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2003
Founded2003
Employees9
Employees9
LACQ Key Statistics
Market cap34.68M
Market cap34.68M
Price-Earnings ratio-0.55
Price-Earnings ratio-0.55
Dividend yield—
Dividend yield—
Average volume65.71K
Average volume65.71K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.67
52 Week high$14.67
52 Week low$1.62
52 Week low$1.62
Stock Snapshot
With a market cap of 34.68M, Leisure Acquisition(LACQ) trades at $14.49. The stock has a price-to-earnings ratio of -0.55.
On 2025-11-05, Leisure Acquisition(LACQ) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 65.71K.
The stock's 52-week range extends from a low of $1.62 to a high of $14.67.
The stock's 52-week range extends from a low of $1.62 to a high of $14.67.
People also own
Based on the portfolios of people who own LACQ. This list is generated using Robinhood data, and it’s not a recommendation.